Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/07/020290
CTRI/2019/07/020290
Completed
未知

Prediction of treatment response in Depression using Quantitative Electroencephalography

GMCH Chandigarh0 sites80 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: F332- Major depressive disorder, recurrent severe without psychotic featuresHealth Condition 2: F331- Major depressive disorder, recurrent, moderateHealth Condition 3: F321- Major depressive disorder, singleepisode, moderateHealth Condition 4: F322- Major depressive disorder, singleepisode, severe without psychotic features

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: F332- Major depressive disorder, recurrent severe without psychotic featuresHealth Condition 2: F331- Major depressive disorder, recurrent, moderateHealth Condition 3: F321- Major depressive disorder, singleepisode, moderateHealth Condition 4: F322- Major depressive disorder, singleepisode, severe without psychotic features
Sponsor
GMCH Chandigarh
Enrollment
80
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
November 28, 2020
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
GMCH Chandigarh

Eligibility Criteria

Inclusion Criteria

  • •1\.Age group 18 \- 65 years
  • •2\.Major Depressive Disorder (Single or Recurrent )
  • •3\.Hamilton Rating Scale for Depression(Ham\-D) Score more than 14

Exclusion Criteria

  • •1\.Bipolar disorder or psychosis
  • •2\.Epilepsy or any other condition requiring anticonvulsants
  • •3\.Any Significant Medical or Surgical abnormalities
  • •4\.Dementia
  • •5\.Anxiety Disorders
  • •6\.Any treatment ( pharmacological, psychotherapy or somatic therapy) in current episode
  • •7\.Patient on any Psychotropic drug in past 2 weeks
  • •8\.Substance Dependence(including nicotine and caffeine) in past six months
  • •9\.Pregnant or Breastfeeding Females
  • •10\.Significant suicidal risk

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Investigating predictors of response to Transcranial Magnetic Stimulation for the treatment of depressio
ACTRN12610001071011Professor Paul Fitzgerald120
Recruiting
Not Applicable
A Study of Depressive Symptoms and Therapeutic Decision Making in Mood Disordersmood disorder
JPRN-UMIN000045793The Jikei University School of Medicine200
Completed
Phase 2
Evaluation the response rate in major depressive disorder after taking Sertraline as a predictive factor base on motor cortex magnetic brain stimulation.The effect of sertraline in major depressive disorder.Major depressive disorder, single episode
IRCT20100119003106N44Islamic Azad University48
Recruiting
Not Applicable
Prediction of the Therapeutic Response in Depression Based on Neuro-computational Modeling Assessment of MotivationMajor Depressive Disorder
NCT05866575Centre Hospitalier St Anne136
Completed
Not Applicable
Effectiveness of the follow-up of depressed patients by nursesMajor depressionMental and Behavioural Disorders
ISRCTN08808171Jordi Gol i Gurina Primary Care Research Institute (IDIAP Jordi Gol i Gurina) (Spain)460